BIOVECTRA
Matthew Harty is a Principal Scientist at BIOVECTRA, where Matthew oversees the Process Development Analytical Services group. With a Master's Degree in Biochemistry and Molecular Biology from Dalhousie University, Matthew has a wide range of experience in analytical chemistry, biochemistry research, and teaching assistant roles. Matthew also has a background as an Infantry Soldier with the Canadian Armed Forces.
This person is not in any offices
BIOVECTRA
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemicaland biologic molecules, downstream processing, MPEG production, and conjugation chemistry.BioVectra was founded on 1970 and is based in Charlottetown, Canada.